Tolebrutinib Archives - Medical Conferences

Paramagnetic rim lesions predict effectiveness of tolebrutinib

Presented By

Dr Jiwon Oh, University of Toronto, Canada

Trial

HERCULES, GEMINI

Conference

ACTRIMS 2025

Type

News article

28 March 2025 11:34

Meet the Trialist: Dr Jiwon Oh

Expert

Dr Jiwon Oh, St Michael’s Hospital, University of Toronto, Canada

Conference

ACTRIMS 2025

5 March 2025 10:59

Tolebrutinib slows disability worsening in relapsing MS

Presented By

Dr Jiwon Oh, St. Michael's Hospital, Canada

Trial

Phase 3, GEMINI 1, GEMINI 2

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:21

Tolebrutinib slows disability in non-relapsing SPMS

Presented By

Prof. Robert Fox, Cleveland Clinic, OH, USA

Trial

Phase 3, HERCULES

Conference

ECTRIMS 2024

Type

Peer-reviewed article

18 November 2024 12:13

Tolebrutinib reduces brain lesions in very active MS

Trial

Phase 2

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:50

Targeting cells in the CNS key to abrogate multiple sclerosis progression

Presented By

Prof. Tony Traboulsee , University of British Columbia, Vancouver, Canada

Conference

AAN 2021

29 April 2021 13:22